Literature DB >> 25105544

Understanding and preventing the development of post-stroke dementia.

Masafumi Ihara1, Raj N Kalaria.   

Abstract

Post-stroke dementia (PSD) is a clinical entity but it now appears that most of PSD may be categorized as vascular dementia. The well-established relationship between vascular factors and dementia provides a rationale for the implementation of intervention and prevention efforts. Larger primary prevention trials related to lifestyle factors are warranted in association with dementia. Published clinical trials have not been promising and there is meager information on whether PSD can be prevented through the use of pharmacological agents. Control of vascular disease risk and prevention of recurrent strokes are obviously key to reducing the burden of cognitive decline and dementia after stroke. However, modern imaging and analysis techniques will help to elucidate the mechanism of PSD and establish better treatment.

Entities:  

Keywords:  Alzheimer’s disease; cognitive impairment; dementia; microinfarct; neuroimaging; post-stroke dementia; stroke; vascular dementia; white matter

Mesh:

Substances:

Year:  2014        PMID: 25105544     DOI: 10.1586/14737175.2014.947276

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  9 in total

Review 1.  Pathological role of apoptosis signal-regulating kinase 1 in human diseases and its potential as a therapeutic target for cognitive disorders.

Authors:  So Yeong Cheon; Kyoung Joo Cho
Journal:  J Mol Med (Berl)       Date:  2019-01-07       Impact factor: 4.599

2.  Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and post-stroke dementia: a hospital-based study from northern Iran.

Authors:  Sajjad Rezaei; Karim Asgari Mobarake; Alia Saberi; Parvaneh Keshavarz; Ehsan Kazemnejad Leili
Journal:  Neurol Sci       Date:  2016-04-12       Impact factor: 3.307

3.  Effect of stent-assisted angioplasty on cognitive status and serum levels of amyloid beta in patients with intracranial and/or extracranial artery stenosis.

Authors:  Liandong Zhao; Ying Zhao; Haijun Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-24       Impact factor: 2.570

4.  Mild cognitive impairment: vascular risk factors in community elderly in four cities of Hebei Province, China.

Authors:  Yumei Wang; Mei Song; Lulu Yu; Lan Wang; Cuixia An; Shunjiang Xun; Xiaochuan Zhao; Yuanyuan Gao; Xueyi Wang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Hypertension, diabetes and obesity are associated with lower cognitive performance in community-dwelling elderly: Data from the FIBRA study.

Authors:  Monalisa Fernanda Bocchi de Oliveira; Mônica Sanches Yassuda; Ivan Aprahamian; Anita Liberalesso Neri; Maria Elena Guariento
Journal:  Dement Neuropsychol       Date:  2017 Oct-Dec

Review 6.  Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.

Authors:  Masafumi Ihara; Kazuo Washida
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Effect of Selective 5-HT6R Agonist on Expression of 5-HT Receptor and Neurotransmitter in Vascular Dementia Rats.

Authors:  Haining Yu; Tao Chen; Li Zhou; Jiyou Tang
Journal:  Med Sci Monit       Date:  2017-02-15

8.  Clinical Risk Score for Predicting Vascular Dementia after Ischemic Stroke in Thailand.

Authors:  Pornpatr A Dharmasaroja; Thammanard Charernboon
Journal:  Stroke Res Treat       Date:  2022-09-26

9.  Cerebrolysin for vascular dementia.

Authors:  Shuhui Cui; Ning Chen; Mi Yang; Jian Guo; Muke Zhou; Cairong Zhu; Li He
Journal:  Cochrane Database Syst Rev       Date:  2019-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.